| Literature DB >> 23997955 |
Rubén Cuesta-Barriuso1, Antonia Gómez-Conesa, José Antonio López-Pina.
Abstract
Haemophilic arthropathy of the ankle causes pain and deterioration in gait, causing disability. Although some physiotherapy modalities are effective in the management of acute bleeding, the results are unknown in chronic arthropathy. Our objective was to determine the most effective physiotherapy procedures for treating the haemophilic arthropathy of the ankle and to assess the methodological quality of the studies. A systematic review was carried out in the Cochrane Database, PubMed, MEDLINE, ISI Web of Knowledge, PEDro, TESEO, and specialized journals (Haemophilia and Haematologica). It included articles with at least one group undergoing any kind of physiotherapy treatment and with pretest and posttest evaluation, published before April 2013. An analysis of variables was performed and assessed the methodological quality of studies. Five studies met the criteria for inclusion. Hydrotherapy treatments, strength training and balance strength, balance training, and sports therapy, have improved range of movement, pain, balance, and subjective physical performance. The proposed methodological analysis was not possible due to the low quality of the studies. Although the results are positive, they lack rigorous evidence on the effects of treatments. Studies are needed to establish the efficacy of the various forms of physiotherapy in the haemophilic arthropathy of the ankle.Entities:
Year: 2013 PMID: 23997955 PMCID: PMC3753735 DOI: 10.1155/2013/305249
Source DB: PubMed Journal: Rehabil Res Pract ISSN: 2090-2867
Figure 1Details of the studies included in the review (min: minutes).
| Gurcay et al. (2008) [ | Hilberg et al. (2003) [ |
Garcia et al. (2009) [ | Hill et al. (2010) [ | Czepa et al. (2013) [ | |
|---|---|---|---|---|---|
| Type of study | Pretest-posttest study | Pretest-postest study with control group being not homogeneus | Pretest-postest study with control group being not homogeneus | Pretest-postest study | Pretest-postest study with two control groups |
|
| |||||
| Participants | 31 patients with hemophilia. Mean age: 13.02 y | 9 patients with hemophilia (experimental group), 8 subjects without hemophilia (active control group, AC), and 11 subjects without hemophilia (passive control group, PC). | 9 patients with hemophilia and arthropathy (experimental group) and 9 patients with no pathology or articular anomaly. | 20 patients with hemophilia. | 13 patients with hemophilia (active PwH), 12 patients with hemophilia (passive PwH), and 19 subjects without hemophilia (controls) |
|
| |||||
| Experimental versus control intervention (no. of participants) | Isometric, isotonic, strengthening, and proprioception exercise ( | Strength and propioception training ( | Vertical bicycle, ability to control breathing, ability to control the rotations, and activities for balance, buoyancy, and immobility control ( | Balance and lower limb strength exercises and a walking programme ( | Sports therapy with exercise to increase focal points in terms of body awareness, muscle tone regulation, joint mobilization, and muscle activation |
|
| |||||
| Duration | 4 weeks | 24 weeks | 4 weeks | 16 weeks | 52 weeks |
|
| |||||
| Frequency | 5 times/week | 2 times/week | 2 times/week | 5–7 times/week | 1 time/week (0.98 point in scale 0–4) |
|
| |||||
| Intensity | 300 minutes/week | 240 minutes/week | 60 minutes/week | No data | No data |
|
| |||||
| Outcomes of experimental group | Significant changes in flexion and dorsiflexion ( | One-leg-stand test: differences between H and PC groups ( | Significant changes in the ROM of left ankle in hemophilia ankle: between sessions ( | Significant changes in static balance ( | Active PwH reported significant changes in subjective physical performance in the HEP-test-Q domains “strength and coordination,” “endurance,” and “body perception” as well as the total score compared to the other groups. |
|
| |||||
| Measuring instruments | Goniometer (ROM), Jafar-C (functional disability), EVA (pain. score 0–3), and clinical evaluation score (adopted by WFH) | One-leg-stand test, Posturomed test, angle reproduction test, and tuning fork test (propioception); strength test (isometric muscular strength) | Goniometer (ROM) | Functional Reach test, step test, and timed up and go test (clinical measures of balance); mCTSIB test and LOS test (laboratory measures of balance); walking across the long plate test and step and quick turn (gait measures); Human Activity Profile (physical activity); MFES (falls Efficacy); and VAS (pain. score 0–10) | Activity level (scale 0–4), goniometer (ROM), one-leg-stand test, and 12 min walk test |
|
| |||||
| Pharmacology Cointervention | Prophylaxis treatment (2-3 times/week) | Prophylaxis treatment (if necessary) | No data | No data | Patients were on prophylaxis or on demand treatment, according to medical criteria |
|
| |||||
| Adverse effects | 2 patients developed hemarthrosis during treatment | No patient developed hemarthrosis during treatment | No data | No patient developed hemarthrosis during treatment. | No patient developed haemarthrosis during treatment. |
Description of the qualitative moderating variables.
| Variables |
| Frequency | % | |
|---|---|---|---|---|
| Treatment variables | ||||
| Type of treatment | 5 | ST + PT | 3 | 60 |
| H | 1 | 20 | ||
| SPORT | 1 | 20 | ||
| Mode of application | 5 | Direct | 2 | 40 |
| Indirect | 2 | 40 | ||
| Mixed | 1 | 20 | ||
| Informed consent | 5 | Yes | 3 | 50 |
| No | 2 | 50 | ||
|
| ||||
| Context variables | ||||
| Country | 5 | Germany | 2 | 25 |
| Brazil | 1 | 25 | ||
| Australia | 1 | 25 | ||
| Turkey | 1 | 25 | ||
| Place | 5 | Hospital | 3 | 75 |
| Domiciliary | 2 | 25 | ||
|
| ||||
| Methodological variables | ||||
| Pretest | 5 | Yes | 5 | 100 |
| No | 0 | 0 | ||
| Assignment | 5 | Random | 0 | 0 |
| Not random | 5 | 100 | ||
| Control group | 5 | Yes | 1 | 0 |
| No | 4 | 100 | ||
| Date | 5 | 2003 | 1 | 25 |
| 2005–2013 | 4 | 75 | ||
| Published | 5 | Yes | 5 | 100 |
| No | 0 | 0 | ||
| Source | 5 | Journal article | 5 | 100 |
k: number of studies; ST: strength training; PT: proprioception training; H: hydrotherapy; SPORT: sports therapy.
Description of the quantitative moderating variables: duration (weeks); intensity (hours/week); magnitude (total hours); SS (size of the sample).
| Moderating variables |
| Min. | Max. | Average | Median | DT |
|---|---|---|---|---|---|---|
| Treatment variables | ||||||
| Duration | 5 | 4 | 52 | 20 | 16 | 19.79 |
| Intensity | 3 | 1 | 5 | 3.33 | 4.00 | 2.081 |
| Magnitude | 3 | 4 | 96 | 40.00 | 20.00 | 49.153 |
| Subject variables | ||||||
| Age (years) | 4 | 13.02 | 45 | 32.45 | 35.90 | 13.944 |
| Methodological variables | ||||||
| SS treatment group pretest | 5 | 9 | 35 | 18.80 | 20 | 10.73 |
| SS treatment group posttest | 5 | 9 | 31 | 14.80 | 12 | 9.23 |
| SS treatment group followup | 0 | |||||
| SS control group pretest | 1 | 0 | 27 | 5.40 | 0 | 12.074 |
| SS control group postest | 1 | 0 | 12 | 2.40 | 0 | 5.366 |
| SS control group followup | 0 | |||||
| Postest differential mortality (%) | 5 | 0 | 52.80 | 20.8444 | 11.42 | 24.17 |
| Differential mortality followup (%) | 0 |
Analysis of the methodological quality of Czepa et al.'s [14] study, by Van Tulder scale.
| Items | Czepa et al. (2013) [ |
|---|---|
| Was the method of randomization adequate? | No |
| Was the treatment allocation concealed? | No |
| Were the groups similar at baseline regarding the most important prognostic indicators? | Yes |
| Was the patient blinded to the intervention? | No |
| Was the care provider blinded to the intervention? | No |
| Was the outcome assessor blinded to the intervention? | No |
| Were cointerventions avoided or similar? | No |
| Was the compliance acceptable in all groups? | No |
| Was the drop-out rate described and acceptable? | No |
| Was the timing of the outcome assessment in all groups similar? | Yes |
| Did the analysis include an intention-to-treat analysis? | No |
Analysis of the methodological quality of Czepa et al.'s [14] study, by PEDro scale.
| Items | Czepa et al. (2013) [ |
|---|---|
| Eligibility criteria were specified | No |
| Subjects were randomly allocated to groups (in a crossover study, subjects were randomly allocated an order in which treatments were received) | No |
| Allocation was concealed | No |
| The groups were similar at baseline regarding the most important prognostic indicators | Yes |
| There was blinding of all subjects | No |
| There was blinding of all therapists who administered the therapy | No |
| There was blinding of all assessors who measured at least one key outcome | No |
| Measures of at least one key outcome were obtained from more than 85% of the subjects initially allocated to groups | No |
| All subjects for whom outcome measures were available received the treatment or control condition as allocated or, where this was not the case, data for at least one key outcome was analysed by “intention to treat” | No |
| The results of between-group statistical comparisons are reported for at least one key outcome | Yes |
| The study provides both point measures and measures of variability for at least one key outcome | Yes |